Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 21 | 2021 | 197 | 5.230 |
Why?
|
| Drosophila Proteins | 27 | 2026 | 718 | 4.440 |
Why?
|
| Glucosyltransferases | 15 | 2025 | 44 | 3.990 |
Why?
|
| Drosophila | 17 | 2023 | 739 | 3.470 |
Why?
|
| Alagille Syndrome | 4 | 2025 | 54 | 2.690 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 5 | 2022 | 11 | 2.180 |
Why?
|
| Liver | 6 | 2025 | 1796 | 2.080 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2022 | 50 | 2.000 |
Why?
|
| Signal Transduction | 26 | 2026 | 4686 | 1.990 |
Why?
|
| Drosophila melanogaster | 15 | 2026 | 789 | 1.870 |
Why?
|
| Polysaccharides | 5 | 2026 | 143 | 1.680 |
Why?
|
| Glycosyltransferases | 6 | 2025 | 26 | 1.570 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2023 | 288 | 1.160 |
Why?
|
| Epidermal Growth Factor | 4 | 2018 | 115 | 1.160 |
Why?
|
| Glycosylation | 12 | 2026 | 127 | 1.040 |
Why?
|
| Animals | 49 | 2026 | 33912 | 1.030 |
Why?
|
| SOX9 Transcription Factor | 3 | 2025 | 82 | 0.980 |
Why?
|
| Serrate-Jagged Proteins | 5 | 2023 | 35 | 0.930 |
Why?
|
| Membrane Proteins | 9 | 2026 | 1590 | 0.920 |
Why?
|
| Jagged-1 Protein | 7 | 2025 | 51 | 0.920 |
Why?
|
| Calcium-Binding Proteins | 5 | 2026 | 325 | 0.900 |
Why?
|
| SOXC Transcription Factors | 1 | 2025 | 13 | 0.900 |
Why?
|
| Muscle Development | 1 | 2025 | 72 | 0.870 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2019 | 15 | 0.840 |
Why?
|
| Dependovirus | 1 | 2025 | 160 | 0.800 |
Why?
|
| Lipolysis | 1 | 2023 | 83 | 0.780 |
Why?
|
| Wings, Animal | 3 | 2017 | 28 | 0.770 |
Why?
|
| Pentosyltransferases | 3 | 2018 | 18 | 0.760 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 70 | 0.740 |
Why?
|
| Bile Ducts | 2 | 2020 | 52 | 0.730 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2022 | 22 | 0.720 |
Why?
|
| Transcription Factors | 6 | 2017 | 2406 | 0.650 |
Why?
|
| Genetic Therapy | 1 | 2025 | 713 | 0.630 |
Why?
|
| Fucosyltransferases | 1 | 2019 | 25 | 0.610 |
Why?
|
| Protein Kinases | 2 | 2020 | 312 | 0.600 |
Why?
|
| Genetic Background | 1 | 2018 | 7 | 0.570 |
Why?
|
| Glycomics | 1 | 2018 | 15 | 0.570 |
Why?
|
| Liver Diseases | 2 | 2019 | 385 | 0.560 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 344 | 0.560 |
Why?
|
| Glycoproteins | 1 | 2020 | 346 | 0.550 |
Why?
|
| Xylose | 2 | 2017 | 6 | 0.530 |
Why?
|
| Imaginal Discs | 1 | 2017 | 9 | 0.520 |
Why?
|
| Heterozygote | 2 | 2020 | 737 | 0.510 |
Why?
|
| Sense Organs | 4 | 2006 | 16 | 0.490 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 127 | 0.490 |
Why?
|
| Transgenes | 4 | 2014 | 316 | 0.480 |
Why?
|
| Rare Diseases | 1 | 2018 | 210 | 0.480 |
Why?
|
| Receptor, Notch3 | 2 | 2026 | 12 | 0.480 |
Why?
|
| Mice | 14 | 2026 | 18301 | 0.480 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 16 | 0.460 |
Why?
|
| Gene Silencing | 3 | 2025 | 229 | 0.440 |
Why?
|
| Photoreceptor Cells | 1 | 2014 | 89 | 0.420 |
Why?
|
| Phenotype | 6 | 2025 | 4497 | 0.420 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 77 | 0.410 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 555 | 0.400 |
Why?
|
| Eye Proteins | 1 | 2014 | 221 | 0.390 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2025 | 36 | 0.380 |
Why?
|
| Gene Deletion | 1 | 2015 | 767 | 0.370 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2019 | 18 | 0.370 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 1211 | 0.370 |
Why?
|
| Mutation | 13 | 2020 | 6099 | 0.330 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 2323 | 0.330 |
Why?
|
| Stem Cells | 3 | 2025 | 702 | 0.320 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1928 | 0.300 |
Why?
|
| Genetic Techniques | 1 | 2010 | 95 | 0.300 |
Why?
|
| Embryonic Development | 1 | 2011 | 200 | 0.300 |
Why?
|
| Humans | 25 | 2026 | 131163 | 0.290 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2020 | 25 | 0.280 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2023 | 103 | 0.270 |
Why?
|
| Ligands | 3 | 2018 | 481 | 0.260 |
Why?
|
| Genes, Insect | 2 | 2008 | 100 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4697 | 0.250 |
Why?
|
| eIF-2 Kinase | 1 | 2026 | 37 | 0.240 |
Why?
|
| Muscle, Skeletal | 2 | 2025 | 981 | 0.240 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2026 | 42 | 0.240 |
Why?
|
| Stem Cell Niche | 1 | 2026 | 55 | 0.240 |
Why?
|
| Endoplasmic Reticulum | 2 | 2026 | 208 | 0.240 |
Why?
|
| Endocytosis | 2 | 2005 | 121 | 0.230 |
Why?
|
| Receptor, Notch2 | 1 | 2025 | 12 | 0.230 |
Why?
|
| PAX7 Transcription Factor | 1 | 2025 | 21 | 0.230 |
Why?
|
| Myoblasts | 1 | 2025 | 32 | 0.230 |
Why?
|
| Glucose | 4 | 2014 | 853 | 0.220 |
Why?
|
| Receptor, Notch1 | 1 | 2025 | 78 | 0.220 |
Why?
|
| Neurons | 5 | 2006 | 1979 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 4 | 2026 | 4738 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 138 | 0.210 |
Why?
|
| Cell Lineage | 2 | 2006 | 349 | 0.210 |
Why?
|
| Zinc Fingers | 1 | 2004 | 116 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 950 | 0.210 |
Why?
|
| Regeneration | 1 | 2026 | 230 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2465 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2004 | 106 | 0.200 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 1939 | 0.200 |
Why?
|
| Oocytes | 1 | 2005 | 283 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2020 | 849 | 0.190 |
Why?
|
| Enterocytes | 1 | 2023 | 68 | 0.190 |
Why?
|
| Juvenile Hormones | 1 | 2002 | 4 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2026 | 619 | 0.180 |
Why?
|
| Body Patterning | 1 | 2002 | 122 | 0.180 |
Why?
|
| Repressor Proteins | 5 | 2008 | 760 | 0.180 |
Why?
|
| Cell Line | 6 | 2017 | 2552 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3819 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2006 | 905 | 0.170 |
Why?
|
| Genetic Vectors | 1 | 2025 | 892 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2326 | 0.170 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Cholestasis | 1 | 2023 | 170 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2023 | 502 | 0.160 |
Why?
|
| Dystroglycans | 1 | 2020 | 11 | 0.150 |
Why?
|
| Lipids | 1 | 2023 | 569 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 716 | 0.150 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 57 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 357 | 0.150 |
Why?
|
| Portal Vein | 1 | 2019 | 84 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2020 | 232 | 0.140 |
Why?
|
| Cell Aggregation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Protein Binding | 4 | 2017 | 1652 | 0.140 |
Why?
|
| Base Sequence | 3 | 2014 | 2730 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2002 | 993 | 0.130 |
Why?
|
| Nervous System | 3 | 2006 | 114 | 0.120 |
Why?
|
| Protein Folding | 2 | 2015 | 214 | 0.120 |
Why?
|
| Peptide Mapping | 1 | 2016 | 33 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2018 | 919 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 51 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2885 | 0.120 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 291 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 804 | 0.110 |
Why?
|
| Growth and Development | 1 | 2015 | 19 | 0.110 |
Why?
|
| Molecular Sequence Data | 6 | 2007 | 3464 | 0.110 |
Why?
|
| Hepatic Insufficiency | 1 | 2015 | 2 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 2395 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 211 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 420 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2015 | 31 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 238 | 0.110 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2015 | 41 | 0.110 |
Why?
|
| Enzyme Assays | 2 | 2015 | 11 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1833 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 118 | 0.100 |
Why?
|
| Recombination, Genetic | 2 | 2014 | 422 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 130 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 300 | 0.100 |
Why?
|
| Temperature | 2 | 2011 | 291 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 708 | 0.090 |
Why?
|
| Models, Biological | 5 | 2014 | 1371 | 0.090 |
Why?
|
| Biomarkers | 1 | 2022 | 3385 | 0.090 |
Why?
|
| Receptors, Serotonin | 2 | 2003 | 37 | 0.090 |
Why?
|
| Factor VII | 1 | 2011 | 17 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 141 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3061 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 74 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 51 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2026 | 588 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 356 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 491 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 781 | 0.080 |
Why?
|
| Seizures | 1 | 2015 | 890 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 435 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 1075 | 0.070 |
Why?
|
| Apoptosis | 2 | 2005 | 1827 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 359 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 274 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 40 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2550 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 775 | 0.060 |
Why?
|
| Hexosyltransferases | 1 | 2026 | 8 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 623 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1591 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2006 | 697 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 92 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 52 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 963 | 0.060 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 29 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 1363 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 128 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 366 | 0.050 |
Why?
|
| Raphe Nuclei | 2 | 2003 | 16 | 0.050 |
Why?
|
| Infant | 1 | 2020 | 13352 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 776 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 135 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 269 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2020 | 15110 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 582 | 0.050 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2002 | 2 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2595 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 1207 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2003 | 178 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2026 | 544 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 644 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 150 | 0.040 |
Why?
|
| Child | 1 | 2020 | 26341 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2005 | 1106 | 0.030 |
Why?
|
| Calcium | 1 | 2003 | 1010 | 0.030 |
Why?
|
| Pregnancy | 1 | 2011 | 7512 | 0.030 |
Why?
|
| Spain | 1 | 2016 | 56 | 0.030 |
Why?
|
| Fucose | 1 | 2016 | 18 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 197 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 819 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1677 | 0.030 |
Why?
|
| Male | 4 | 2020 | 64957 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 106 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 142 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 90 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 152 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 362 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 341 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Alleles | 2 | 2008 | 1673 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 759 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 2 | 2003 | 6 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 287 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1692 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1481 | 0.020 |
Why?
|
| Female | 2 | 2020 | 70963 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 953 | 0.020 |
Why?
|
| Spodoptera | 1 | 2008 | 28 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2008 | 54 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 117 | 0.020 |
Why?
|
| Chromosomes | 1 | 2008 | 120 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 199 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 161 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 135 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 215 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 206 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 533 | 0.010 |
Why?
|
| Cyclin E | 1 | 2005 | 30 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 825 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 3370 | 0.010 |
Why?
|
| Ataxins | 1 | 2005 | 109 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2006 | 277 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1046 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 333 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2005 | 168 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 556 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 102 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 55 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 419 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 154 | 0.010 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 5 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2005 | 164 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 645 | 0.010 |
Why?
|
| Meiosis | 1 | 2003 | 111 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 594 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 265 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 780 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 441 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1133 | 0.010 |
Why?
|
| Septum of Brain | 1 | 2000 | 4 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 263 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31282 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2000 | 460 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2833 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 731 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3175 | 0.010 |
Why?
|